Savill Stuart A, Leitch Helen F, Harvey John N, Thomas Trevor H
Betsi Cadwaladr University Health Board, Croesnewydd Road, Wrexham, United Kingdom.
School of Medical Sciences, Wrexham Academic Unit, Bangor University, Bangor, United Kingdom.
PLoS One. 2016 Sep 20;11(9):e0162908. doi: 10.1371/journal.pone.0162908. eCollection 2016.
Cardiovascular disease and cancer are increased in Type 2 diabetes. TPM1 and TPM4 genes encode proteins associated with cardiovascular and neoplastic disease. High (HMW) and low (LMW) molecular weight isoforms from TPM1 and TPM4 are altered in several cancer cells and the 3'UTR of TPM1 mRNA is tumour suppressive. Leukocytes influence cardiovascular and neoplastic disease by immunosurveillance for cancer and by chronic inflammation in Type 2 diabetes and cardiovascular disease. The aim was to determine changes in expression of isoforms from TPM1 and TPM4 genes in leukocytes from Type 2 diabetic patients and to use the leukocyte cell line THP1 to identify possible mediators of changes in the patients. Gene expression was determined by RT-qPCR. In diabetes, expression of HMW isoforms from TPM1 were markedly decreased (0.55 v 1.00; p = 0.019) but HMW isoforms from TPM4 were not significantly different (0.76 v 1.00; p = 0.205). Within individual variance in expression of HMW isoforms was very high. The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNFα (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1α (0.17 and 0.14 v 1.00 respectively). Increased insulin or glucose concentrations had no substantial effects on TPM1 or TPM4 expression. Decreased TPM1 mRNA resulted in decreases in HMW protein levels. Expression of HMW isoforms from TPM1 is decreased in Type 2 diabetes. This is probably due to increased levels of inflammatory cytokines TNFα and IL-1α in Type 2 diabetes. Lower levels of TPM1 mRNA reduce tumour suppression and could contribute to increased cancer risk in Type 2 diabetes. Decreased HMW tropomyosin isoforms are associated with cancer. Decreased HMW isoforms give rise to cells that are more plastic, motile, invasive and prone to dedifferentiation resulting in leukocytes that are more invasive but less functionally effective.
2型糖尿病患者心血管疾病和癌症的发病率增加。TPM1和TPM4基因编码与心血管疾病和肿瘤疾病相关的蛋白质。TPM1和TPM4的高(HMW)分子量和低(LMW)分子量异构体在几种癌细胞中发生改变,并且TPM1 mRNA的3'UTR具有肿瘤抑制作用。白细胞通过对癌症的免疫监视以及2型糖尿病和心血管疾病中的慢性炎症影响心血管疾病和肿瘤疾病。目的是确定2型糖尿病患者白细胞中TPM1和TPM4基因异构体的表达变化,并使用白细胞细胞系THP1来确定患者变化的可能介质。通过RT-qPCR测定基因表达。在糖尿病中,TPM1的HMW异构体表达明显降低(0.55对1.00;p = 0.019),但TPM4的HMW异构体无显著差异(0.76对1.00;p = 0.205)。HMW异构体表达的个体差异非常大。在用1 ng/ml TNFα(分别为0.10和0.12对1.00)或10 ng/ml IL-1α(分别为0.17和0.14对1.00)处理的THP1细胞中,TPM1和TPM4的HMW异构体表达变化得到了重复。胰岛素或葡萄糖浓度升高对TPM1或TPM4表达没有实质性影响。TPM1 mRNA降低导致HMW蛋白水平降低。2型糖尿病中TPM1的HMW异构体表达降低。这可能是由于2型糖尿病中炎性细胞因子TNFα和IL-1α水平升高所致。较低水平的TPM1 mRNA降低了肿瘤抑制作用,并可能导致2型糖尿病患者癌症风险增加。HMW原肌球蛋白异构体减少与癌症有关。HMW异构体减少会产生更具可塑性、运动性、侵袭性且易于去分化的细胞,导致白细胞更具侵袭性但功能效率更低。